Références - Dräger JM-105 Notice D'utilisation

Références
1 Sgro M, et al. Severe Neonatal
Hyperbilirubinemia Decreased after the 2007
Canadian Guidelines. J Pediatr. 2016;171:
43-47.
2 Chawla D, et al. Accuracy of transcutaneous
bilirubin measurement in preterm low-birth-
weight neonates. J Pediatr. 2014;173(2):
173-179.
3 Myers MG, McMahon BJ, Koontz FP. Neonatal
calcaneous osteomyelitis related to
contaminated mineral oil. J. Clin Microbiol.
1977;6(5):543-544.
4 Meites S. Skin-puncture and blood-collecting
technique for infants: update and problems.
Clin Chem. 1988;34(9):1890-1894.
5 Afanetti M, et al. Transcutaneous
bilirubinometry is not influenced by term or
skin color in neonates. Early Hum Dev.
2014;90(8):417-420.
6 Leite M, et al. Comparison of transcutaneous
and plasma bilirubin measurement. TJ Pediatr
(Rio J). 2007;83(3):283-286.
7 Wainer S, et al. Impact of a transcutaneous
bilirubinometry program on resource
utilization and severe hyperbilirubinemia.
IPediatricss. 2012;129(1):77-86.
8 Campbell DM, et al. Transcutaneous bilirubin
measurement at the time of hospital discharge
in a multiethnic newborn population. Paediatr
Child Health. 2011;16(3):141-145.
9 Bhutani VK, Wong RJ. Bilirubin neurotoxicity
in preterm infants: risk and prevention. J Clin
Neonatol. 2013;2(2):61-69.
10 Fine KL, et al. Defining the limitations of
transcutaneous bilirubin measurement in late
preterm newborns. J Perinatol.
2017;37(6):658-661.
11 N D. Clinical Summary Report for the Use on
Preterm Infants. 2013.
Notice d'utilisation JM-105
12 Ebbesen F, Brodersen R. Comparison
between two preparations of human serum
albumin in treatment of neanatal
hyperbilirubinaemia. Acta Pædiatrica.
1982;71(1):85-90.
13 Jangaard K, Curtis H, Goldbloom R.
Estimation of bilirubin using BiliChektrade
mark, a transcutaneous bilirubin
measurement device: Effects of gestational
age and use of phototherapy. Paediatr Child
Health. 2006;11(2):79-83.
14 Schmidt ET, et al. Evaluation of
transcutaneous bilirubinometry in preterm
neonates. J Perinatol. 2009;29(8):564-569.
15 Rubio A, et al. Diagnosis Accuracy of
Transcutaneous Bilirubinometry in Very
Preterm Newborns. Neonatology.
2017;111(1):1-7.
16 Sajjadian N, et al. Transcutaneous bilirubin
measurement in preterm neonates. Acta Med
Iran. 2012;50(11):765-770.
17 Conceicao CM, et al. Influence of assessment
site in measuring transcutaneous bilirubin.
Einstein (Sao Paulo). 2014;12(1):11-15.
18 Kurokawa D, et al. Screening for
Hyperbilirubinemia in Japanese Very Low
Birthweight Infants Using Transcutaneous
Bilirubinometry. J Pediatr. 2016;168:77-81 e1.
19 Kitsommart R, et al. Accuracy of
transcutaneous bilirubin measured by the
BiliCare device in late preterm and term
neonates. J Matern Fetal Neonatal Med.
2016;29(22):3641-3645.
20 Nagasaka M, et al. Transcutaneous bilirubin
monitoring predicts unexplained late-onset
hemolysis in a very low birthweight infant.
BMC Res Notes. 2016;9:153.
Références
119